Your browser doesn't support javascript.
loading
Reproductive Steroid Regulation of Mood and Behavior.
Schiller, Crystal Edler; Johnson, Sarah L; Abate, Anna C; Schmidt, Peter J; Rubinow, David R.
Affiliation
  • Schiller CE; Psychiatry Department, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Johnson SL; Psychiatry Department, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Abate AC; Psychiatry Department, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Schmidt PJ; Section on Behavioral Endocrinology, National Institute of Mental Health, Department of Health and Human Services, Bethesda, Maryland, USA.
  • Rubinow DR; Psychiatry Department, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Compr Physiol ; 6(3): 1135-60, 2016 06 13.
Article in En | MEDLINE | ID: mdl-27347888
ABSTRACT
In this article, we examine evidence supporting the role of reproductive steroids in the regulation of mood and behavior in women and the nature of that role. In the first half of the article, we review evidence for the following (i) the reproductive system is designed to regulate behavior; (ii) from the subcellular to cellular to circuit to behavior, reproductive steroids are powerful neuroregulators; (iii) affective disorders are disorders of behavioral state; and (iv) reproductive steroids affect virtually every system implicated in the pathophysiology of depression. In the second half of the article, we discuss the diagnosis of the three reproductive endocrine-related mood disorders (premenstrual dysphoric disorder, postpartum depression, and perimenopausal depression) and present evidence supporting the relevance of reproductive steroids to these conditions. Existing evidence suggests that changes in reproductive steroid levels during specific reproductive states (i.e., the premenstrual phase of the menstrual cycle, pregnancy, parturition, and the menopause transition) trigger affective dysregulation in susceptible women, thus suggesting the etiopathogenic relevance of these hormonal changes in reproductive mood disorders. Understanding the source of individual susceptibility is critical to both preventing the onset of illness and developing novel, individualized treatments for reproductive-related affective dysregulation. © 2016 American Physiological Society. Compr Physiol 61135-1160, 2016e.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reproduction / Gonadal Steroid Hormones / Mood Disorders Limits: Female / Humans Language: En Journal: Compr Physiol Year: 2016 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reproduction / Gonadal Steroid Hormones / Mood Disorders Limits: Female / Humans Language: En Journal: Compr Physiol Year: 2016 Document type: Article Affiliation country: Estados Unidos